Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study
<i>Re</i>-resection is an effective treatment option for rHCC, with favorable outcomes as measured by DFS and OS, though OS is lower compared to initial hepatectomy. Key prognostic factors include Child-Pugh classification, time to recurrence, tumor differentiation, and satellite nodules.
Authors
- Jiye Zhu (ORCID: https://orcid.org/0000-0003-0456-7584)
- Delin Ma (ORCID: https://orcid.org/0000-0001-6886-9886)
- Jie Gao (ORCID: https://orcid.org/0000-0003-0772-4530)
- Pengcheng Wei (ORCID: https://orcid.org/0000-0003-0002-9439)
- Li Zhao (ORCID: https://orcid.org/0000-0003-0512-2835)
- Qian Cheng (ORCID: https://orcid.org/0000-0003-3621-5743)
- Q H Fan (ORCID: https://orcid.org/0000-0002-9505-4102)
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- Beijing Jishuitan Hospital (CN)
- Peking University Cancer Hospital (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Surgery Open Science
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1016/j.sopen.2024.12.004
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Capital Health Research and Development of Special Fund